Prions and prion-like proteins

Journal of Biological Chemistry

Volumn 289, Issue 29, 2014, Pages 19839-19840

  Fraser, Paul E ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGGREGATES; NEURODEGENERATIVE DISEASES;

ALZHEIMER DISEASE; CONFORMATIONAL TRANSFORMATIONS; NEURODEGENERATIVE DISORDERS; NEUROLOGICAL DISEASE; PARKINSON DISEASE; PRION PROTEIN; PROTEIN AGGREGATES;

PROTEINS;

PRION PROTEIN; TAU PROTEIN;

CONFORMATIONAL TRANSITION; DEGENERATIVE DISEASE; HUMAN; NEUROTOXICITY; NONHUMAN; PRION; PRION DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; SHORT SURVEY; TAUOPATHY; TRANSGENICS; UNFOLDED PROTEIN RESPONSE;

ALZHEIMER DISEASE; NEURODEGENERATIVE DISEASE; PRION; PROTEIN AGGREGATION; PROTEIN MISFOLDING;

ALZHEIMER DISEASE; ANIMALS; HUMANS; MULTIPROTEIN COMPLEXES; PARKINSON DISEASE; PRION DISEASES; PRIONS; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; TAU PROTEINS;

EID: 84904497271     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.R114.583492     Document Type: Short Survey

References (16)

1. Prusiner, S. B. (1982) Novel proteinaceous infectious particles cause scrapie. Science 216, 136-144
2. Colby, D. W., and Prusiner, S. B. (2011) Prions. Cold Spring Harb. Perspect. Biol. 3, a006833
3. Griffith, J. S. (1967) Self-replication and scrapie. Nature 215, 1043-1044
4. Anfinsen, C. B. (1973) Principles that govern the folding of protein chains. Science 181, 223-230
5. Kimberlin, R. H. (1982) Scrapie agent: prions or virinos? Nature 297, 107-108
6. Bruce, M. E., and Dickinson, A. G. (1987) Biological evidence that the scrapie agent has an independent genome. J. Gen. Virol. 68, 79-89
7. Legname, G., Baskakov, I. V., Nguyen, H.-O. B., Riesner, D., Cohen, F. E., DeArmond, S. J., and Prusiner, S. B. (2004) Synthetic mammalian prions. Science 305, 673-676
8. Collinge, J., Whitfield, J., McKintosh, E., Beck, J., Mead, S., Thomas, D. J., and Alpers, M. P. (2006) Kuru in the 21st century: an acquired human prion disease with very long incubation periods. Lancet 367, 2068-2074
9. Will, R. G., Ironside, J. W., Zeidler, M., Cousens, S. N., Estibeiro, K., Alperovitch, A., Poser, S., Pocchiari, M., Hofman, A., and Smith, P. G. (1996) A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347, 921-925
10. Prusiner, S. B. (2012) A unifying role for prions in neurodegenerative diseases. Science 336, 1511-1513
11. Ashe, K. H., and Aguzzi, A. (2013) Prions, prionoids and pathogenic proteins in Alzheimer disease. Prion 7, 55-59
12. Walker, L. C., and LeVine, H., 3rd (2012) Corruption and spread of pathogenic proteins in neurodegenerative diseases. J. Biol. Chem. 287, 33109-33115
13. Watts, J. C., and Prusiner, S. B. (2014) Mouse models for studying the formation and propagation of prions. J. Biol. Chem. 289, 19841-19849
14. Supattapone, S. (2014) Synthesis of high titer infectious prions with cofactor molecules. J. Biol. Chem. 289, 19850-19854
15. Holmes, B., and Diamond, M. I. (2014) Prion-like properties of Tau protein: the importance of extracellular Tau as a therapeutic target. J. Biol. Chem. 289, 19855-19861
16. Halliday, M., Radford, H., and Mallucci, G. R. (2014) Prions: generation and spread versus neurotoxicity. J. Biol. Chem. 289, 19862-19868